Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  cholecalciferol
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
D Vitamin in Treating Patients with Early Stage Prostate Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 to 90
Trial IDs: 101840, NCI-2017-01438, 00019745, NCT01759771
Vitamin D and Calcium Carbonate with or without Pamidronate Disodium in Preventing Bone Loss in Younger Patients Who Have Undergone Stem Cell Transplant to Treat a Hematologic Malignancy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 1 to 17
Trial IDs: 2013LS023, NCI-2014-02310, 1305M34621, CTSI 21472, MT2014-23R, NCT02074631
Cholecalciferol Supplementation in Preventing Lung Cancer in D Vitamin-Deficient Patients with Chronic Obstructive Pulmonary Disease
Status: Active
Phase: Phase II
Type: Prevention
Age: 50 and over
Trial IDs: PRO15020031, NCI-2016-00994, NCT02532062
Cholecalciferol in Reducing Skin Redness and Irritation after Topical Application of Mechlorethamine Hydrochloride Gel in Patients with Fitzpatrick Skin Type I-VI
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: CASE3416, NCI-2017-00638, NCT02968446
Cholecalciferol Supplement in Treating Patients with Localized Prostate Cancer Undergoing Observation
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 128308, NCI-2009-01530, RPCI-I-128308, NCT00887432
Cholecalciferol in Improving Survival in Patients with Newly Diagnosed Cancer with Vitamin D Insufficiency
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: LS1293, NCI-2013-00037, NCT01787409
Cholecalciferol in Treating Patients with Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia with Vitamin D Deficiency
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 556-15, NCI-2015-01502, NCT02553447
Start Over